StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 12/03/2013 -- StockRunway.com issues special report on – ValueClick Inc(NASDAQ:VCLK), Halozyme Therapeutics, Inc.(NASDAQ:HALO), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), U.S. Silica Holdings Inc(NYSE:SLCA)
ValueClick Inc(NASDAQ:VCLK) stock is at $21.44, up +21.92 percent from its previous close of $21.40. The stock opened the session at $21.44 and touched its highest price point at $22.12.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +3.59% during previous three months trade. Its recent trading volume was 1.56million shares in comparison to its usual trading volume of 1.52 million shares. ValueClick, Inc. is a digital marketing services company.
For How Long VCLKwill Fight for Profitability? Read This Trend Analysis report
Halozyme Therapeutics, Inc.(NASDAQ:HALO) stock is at $15.11, up 2.37 percent from its previous close of $21.40. Its today’s volume is1.54million shares in comparison to its usual trading volume of 1.50 million shares. The stock opened the session at $15.16 and touched its highest price point at $15.39.
HALO’s quarterly performance remained green with the percentage of +81.83, while its year to date performance showed that the stock advanced overall +125.19%. Halozyme Therapeutics, Inc. is a biopharmaceutical company.
For How Long HALO’s Gloss will Attract Investors? Find out via this report
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) experienced a upsurge of +2.15% to a market valuation of $1.46B per share for previous trading session. After opening the day at $06.57per share, volume surged to 3.96 million.
During last one month it slipped with the percentage of +51.71. Its year to date performance remained adverse with -26.16%. Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors.
Will ARNA Continue To Move Higher? Find Out Here
U.S. Silica Holdings Inc(NYSE:SLCA) opened its shares at the price of $34.51 for the day, its closing price was $35.25 after gaining +2.14% for the day. The company traded with the total volume of 2.21 million shares while its average trading aptitude remained 1.69 million shares. The company has total of 53.40 million outstanding shares and its total market capitalization is $1.88 Billion. US Silica Holdings, Inc. is a silica sand supplier company. The Company is a producer of industrial minerals, including sand proppants, whole grain silica, ground silica, fine ground silica, calcined kaolin clay and aplite clay.
Why Should Investors Buy SLCA After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)